Involvement of Kv1.5 Protein in Oxidative Vascular Endothelial Cell Injury

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Chen, Wen Liang ^a   Huang, Xiong Qing ^b   Zhao, Li Yan ^c   Li, Jie ^b   Chen, Jian Wen ^b   Xiao, Ying ^b   Huang, Yun Ying ^c   Liu, Jie ^c   Wang, Guan Lei ^c   Guan, Yong Yuan ^c  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

(2 ISOPROPYL 5 METHYLCYCLOHEXY)DIPHENYLPHOSPHINE OXIDE; ANGIOTENSIN II; ANTIOXIDANT; COMPLEMENTARY DNA; OXIDIZED LOW DENSITY LIPOPROTEIN; POTASSIUM CHANNEL KV1.5; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CAROTID ARTERY INJURY; CELL DAMAGE; CELL LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG TARGETING; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MITOCHONDRIAL RESPIRATION; MOLECULAR PATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PROTEIN FUNCTION; PULMONARY ARTERY; RAT; UMBILICAL VEIN ENDOTHELIAL CELL;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CAROTID ARTERIES; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROGEN PEROXIDE; ION CHANNELS; KV1.5 POTASSIUM CHANNEL; LIPOPROTEINS, LDL; MALE; MITOCHONDRIAL PROTEINS; OXIDATIVE STRESS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING;

ADENOVIRIDAE; RATTUS;

EID: 84869824775     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049758     Document Type: Article

References (48)

1. Li JM, Shah AM, (2004) Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol 287: R1014-1030.
2. Chen WL, Qian Y, Meng WF, Pang JY, Lin YC, et al. (2009) A novel marine compound xyloketal B protects against oxidized LDL-induced cell injury in vitro. Biochem Pharmacol 78: 941-950.
3. Galle J, Hansen-Hagge T, Wanner C, Seibold S, (2006) Impact of oxidized low density lipoprotein on vascular cells. Atherosclerosis 185: 219-226.
4. Doughan AK, Harrison DG, Dikalov SI, (2008) Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res 102: 488-496.
5. Sudoh N, Toba K, Akishita M, Ako J, Hashimoto M, et al. (2001) Estrogen prevents oxidative stress-induced endothelial cell apoptosis in rats. Circulation 103: 724-729.
6. Feng J, Wible B, Li GR, Wang Z, Nattel S, (1997) Antisense oligodeoxynucleotides directed against Kv1.5 mRNA specifically inhibit ultrarapid delayed rectifier K+ current in cultured adult human atrial myocytes. Circ Res 80: 572-579.
7. Schumacher SM, McEwen DP, Zhang L, Arendt KL, Van Genderen KM, et al. (2009) Antiarrhythmic drug-induced internalization of the atrial-specific k+ channel kv1.5. Circ Res 104: 1390-1398.
8. Ehrlich JR, Biliczki P, Hohnloser SH, Nattel S, (2008) Atrial-selective approaches for the treatment of atrial fibrillation. J Am Coll Cardiol 51: 787-792.
9. Wulff H, Castle NA, Pardo LA, (2009) Voltage-gated potassium channels as therapeutic targets. Nat Rev Drug Discov 8: 982-1001.
10. Lagrutta A, Wang J, Fermini B, Salata JJ, (2006) Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current. J Pharmacol Exp Ther 317: 1054-1063.
11. Wu S, Fluxe A, Sheffer J, Janusz JM, Blass BE, et al. (2006) Discovery and in vitro/in vivo studies of tetrazole derivatives as Kv1.5 blockers. Bioorg Med Chem Lett 16: 6213-6218.
12. Wirth KJ, Brendel J, Steinmeyer K, Linz DK, Rutten H, et al. (2007) In vitro and in vivo effects of the atrial selective antiarrhythmic compound AVE1231. J Cardiovasc Pharmacol 49: 197-206.
13. Michelakis ED, Thebaud B, Weir EK, Archer SL, (2004) Hypoxic pulmonary vasoconstriction: redox regulation of O2-sensitive K+ channels by a mitochondrial O2-sensor in resistance artery smooth muscle cells. J Mol Cell Cardiol 37: 1119-1136.
14. Archer SL, Gomberg-Maitland M, Maitland ML, Rich S, Garcia JG, et al. (2008) Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer. Am J Physiol Heart Circ Physiol 294: H570-578.
15. Brevnova EE, Platoshyn O, Zhang S, Yuan JX, (2004) Overexpression of human KCNA5 increases IK V and enhances apoptosis. Am J Physiol Cell Physiol 287: C715-722.
16. McMurtry MS, Bonnet S, Wu X, Dyck JR, Haromy A, et al. (2004) Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis. Circ Res 95: 830-840.
17. Bonnet S, Archer SL, Allalunis-Turner J, Haromy A, Beaulieu C, et al. (2007) A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11: 37-51.
18. Baliga RS, MacAllister RJ, Hobbs AJ, (2011) New perspectives for the treatment of pulmonary hypertension. Br J Pharmacol 163: 125-140.
19. Arsenijevic D, Onuma H, Pecqueur C, Raimbault S, Manning BS, et al. (2000) Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet 26: 435-439.
20. Blanc J, Alves-Guerra MC, Esposito B, Rousset S, Gourdy P, et al. (2003) Protective role of uncoupling protein 2 in atherosclerosis. Circulation 107: 388-390.
21. Zhao J, Li L, Ling C, Li J, Pang JY, et al. (2009) Marine compound Xyloketal B protects PC12 cells against OGD-induced cell damage. Brain Res 1302: 240-247.
22. Regan CP, Wallace AA, Cresswell HK, Atkins CL, Lynch JJ Jr, (2006) In vivo cardiac electrophysiologic effects of a novel diphenylphosphine oxide IKur blocker, (2-Isopropyl-5-methylcyclohexyl) diphenylphosphine oxide, in rat and nonhuman primate. J Pharmacol Exp Ther 316: 727-732.
23. Hanna IR, Taniyama Y, Szocs K, Rocic P, Griendling KK, (2002) NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal 4: 899-914.
24. Touyz RM, (2004) Reactive oxygen species and angiotensin II signaling in vascular cells - implications in cardiovascular disease. Braz J Med Biol Res 37: 1263-1273.
25. Dimmeler S, Rippmann V, Weiland U, Haendeler J, Zeiher AM, (1997) Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ Res 81: 970-976.
26. Haim TE, Wang W, Flagg TP, Tones MA, Bahinski A, et al. (2010) Palmitate attenuates myocardial contractility through augmentation of repolarizing Kv currents. J Mol Cell Cardiol 48: 395-405.
27. Zmijewski JW, Moellering DR, Le Goffe C, Landar A, Ramachandran A, et al. (2005) Oxidized LDL induces mitochondrially associated reactive oxygen/nitrogen species formation in endothelial cells. Am J Physiol Heart Circ Physiol 289: H852-861.
28. Zhang L, Zhou G, Song W, Tan X, Guo Y, et al. (2012) Pterostilbene protects vascular endothelial cells against oxidized low-density lipoprotein-induced apoptosis in vitro and in vivo. Apoptosis 17: 25-36.
29. Stump GL, Wallace AA, Regan CP, Lynch JJ Jr, (2005) In vivo antiarrhythmic and cardiac electrophysiologic effects of a novel diphenylphosphine oxide IKur blocker (2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide. J Pharmacol Exp Ther 315: 1362-1367.
30. Xi H, Akishita M, Nagai K, Yu W, Hasegawa H, et al. (2007) Potent free radical scavenger, edaravone, suppresses oxidative stress-induced endothelial damage and early atherosclerosis. Atherosclerosis 191: 281-289.
31. Guo W, Kamiya K, Kada K, Kodama I, Toyama J, (1998) Regulation of cardiac Kv1.5 K+ channel expression by cardiac fibroblasts and mechanical load in cultured newborn rat ventricular myocytes. J Mol Cell Cardiol 30: 157-166.
32. Moreno I, Caballero R, Gonzalez T, Arias C, Valenzuela C, et al. (2003) Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization. J Pharmacol Exp Ther 304: 862-873.
33. Chen J, Mehta JL, Haider N, Zhang X, Narula J, et al. (2004) Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells. Circ Res 94: 370-376.
34. Kume N, Kita T, (2004) Apoptosis of vascular cells by oxidized LDL: involvement of caspases and LOX-1 and its implication in atherosclerotic plaque rupture. Circ Res 94: 269-270.
35. Frey RS, Ushio-Fukai M, Malik AB, (2009) NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology. Antioxid Redox Signal 11: 791-810.
36. Moukdar F, Robidoux J, Lyght O, Pi J, Daniel KW, et al. (2009) Reduced antioxidant capacity and diet-induced atherosclerosis in uncoupling protein-2-deficient mice. J Lipid Res 50: 59-70.
37. Roy Chowdhury SK, Sangle GV, Xie X, Stelmack GL, Halayko AJ, et al. (2009) Effects of extensively oxidized low-density lipoprotein on mitochondrial function and reactive oxygen species in porcine aortic endothelial cells. Am J Physiol Endocrinol Metab 298: E89-98.
38. Zmijewski JW, Landar A, Watanabe N, Dickinson DA, Noguchi N, et al. (2005) Cell signalling by oxidized lipids and the role of reactive oxygen species in the endothelium. Biochem Soc Trans 33: 1385-1389.
39. Puddu P, Puddu GM, Cravero E, De Pascalis S, Muscari A, (2009) The emerging role of cardiovascular risk factor-induced mitochondrial dysfunction in atherogenesis. J Biomed Sci 16: 112.
40. Teshima Y, Akao M, Jones SP, Marban E, (2003) Uncoupling protein-2 overexpression inhibits mitochondrial death pathway in cardiomyocytes. Circ Res 93: 192-200.
41. Derdak Z, Garcia TA, Baffy G, (2009) Detection of uncoupling protein-2 (UCP2) as a mitochondrial modulator of apoptosis. Methods Mol Biol 559: 205-217.
42. Tian XY, Wong WT, Xu A, Lu Y, Zhang Y, et al. (2012) Uncoupling protein-2 protects endothelial function in diet-induced obese mice. Circ Res 110: 1211-1216.
43. Lee KU, Lee IK, Han J, Song DK, Kim YM, et al. (2005) Effects of recombinant adenovirus-mediated uncoupling protein 2 overexpression on endothelial function and apoptosis. Circ Res 96: 1200-1207.
44. Ayyasamy V, Owens KM, Desouki MM, Liang P, Bakin A, et al. (2011) Cellular model of Warburg effect identifies tumor promoting function of UCP2 in breast cancer and its suppression by genipin. PLoS One 6: e24792.
45. Sayeed A, Meng Z, Luciani G, Chen LC, Bennington JL, et al. (2010) Negative regulation of UCP2 by TGFbeta signaling characterizes low and intermediate-grade primary breast cancer. Cell Death Dis 1: e53.
46. Stuelten CH, Buck MB, Dippon J, Roberts AB, Fritz P, et al. (2006) Smad4-expression is decreased in breast cancer tissues: a retrospective study. BMC Cancer 6: 25.
47. He X, Gao X, Peng L, Wang S, Zhu Y, et al. (2011) Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7. Circ Res 108: 164-175.
48. Song CY, Kim BC, Hong HK, Lee HS, (2005) Oxidized LDL activates PAI-1 transcription through autocrine activation of TGF-beta signaling in mesangial cells. Kidney Int 67: 1743-1752.